{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470454750
| IUPAC_name = 4-[(Dichloroacetyl)(methyl)amino]phenyl furan-2-carboxylate
| image = Diloxanide furoate.svg
| drug_name = Diloxanide furoate

<!--Clinical data-->
| tradename = Furamide
| Drugs.com = {{drugs.com|CONS|diloxanide}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = No available data
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA_comment = Not approved<!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US_comment = Not approved<!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = by mouth

<!--Pharmacokinetic data-->
| bioavailability = 90% (diloxanide)
| protein_bound =  
| metabolism = [[hydrolysis|Hydrolyzed]] to furoic acid and diloxanide, which undergoes extensive [[glucuronidation]]
| elimination_half-life = 3 hours
| excretion = [[Kidney]] (90%), fecal (10%)

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 3736-81-0
| ATC_prefix = P01
| ATC_suffix = AC01
| PubChem = 19529
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB08792
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 18400
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02480
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1334860

<!--Chemical data-->
| C=14 | H=11 | Cl=2 | N=1 | O=4 
| molecular_weight = 328.147 g/mol
| smiles = O=C(Oc1ccc(N(C(=O)C(Cl)Cl)C)cc1)c2occc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H11Cl2NO4/c1-17(13(18)12(15)16)9-4-6-10(7-5-9)21-14(19)11-3-2-8-20-11/h2-8,12H,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BDYYDXJSHYEDGB-UHFFFAOYSA-N
}}

<!-- Definition and medical uses -->
'''Diloxanide''' is a medication used to treat [[amebiasis|amoeba infections]].<ref name=WHO2008/> It is a second line treatment after [[paromomycin]] when no symptoms are present in places where infections are not common.<ref name=Nat2006rev/> For people who are symptomatic, it is used after treatment with [[metronidazole]] or [[tinidazole]].<ref name=Nat2006rev/> It is taken by mouth.<ref name=WHO2008/>

<!-- Side effects and mechanism -->
Diloxanide generally has mild side effects.<ref name=Hell2003/> Side effects may include [[flatulence]], vomiting, and itchiness.<ref name=WHO2008/> During [[pregnancy]] it is recommended that it be taken after the [[first trimester]].<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|pages=179, 587|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=13 December 2016|df=}}</ref> It is a [[Amebicide#Luminal amebicides|luminal amebicide]] meaning that it only works on infections within the [[intestines]].<ref name=Nat2006rev>{{cite journal|last1=Farthing|first1=Michael JG|title=Treatment options for the eradication of intestinal protozoa|journal=Nature Clinical Practice Gastroenterology & Hepatology|date=August 2006|volume=3|issue=8|pages=436–445|doi=10.1038/ncpgasthep0557|pmid=16883348|url=http://www.nature.com/nrgastro/journal/v3/n8/full/ncpgasthep0557.html|deadurl=no|archiveurl=https://web.archive.org/web/20150621175748/http://www.nature.com/nrgastro/journal/v3/n8/full/ncpgasthep0557.html|archivedate=2015-06-21|df=}}</ref>

<!-- Society and culture -->
Diloxanide came into medical use in 1956.<ref name=Hell2003>{{cite book|last1=Hellgren|first1=Urban|last2=Ericsson|first2=Orjan|last3=AdenAbdi|first3=Yakoub|last4=Gustafsson|first4=Lars L.|title=Handbook of Drugs for Tropical Parasitic Infections|date=2003|publisher=CRC Press|isbn=9780203211519|page=57|url=https://books.google.ca/books?id=DYc7bY-egLEC&pg=PA57|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20161220074428/https://books.google.ca/books?id=DYc7bY-egLEC&pg=PA57|archivedate=2016-12-20|df=}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> It is not commercially available in much of the [[developed world]] as of 2012.<ref name=Kucers2012>{{cite book|last1=Griffin|first1=Paul M|editor1-last=Grayson|editor1-first=M. Lindsay|title=Kucers' the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs|date=2012|publisher=CRC Press|location=Boca Raton, FL|isbn=9781444147520|page=2121|edition=6th|url=https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2121|chapter=Chapter 181: Diloxanide furoate|deadurl=no|archiveurl=https://web.archive.org/web/20170910151801/https://books.google.com/books?id=XR3cBQAAQBAJ&pg=PA2121|archivedate=2017-09-10|df=}}</ref>

== Medical uses ==
Dloxanide furoate works only in the digestive tract and is a [[Amebicide#Lumenal amebicides|lumenal amebicide]].<ref name=Nat2006rev/><ref name=WHOmodel1995>{{cite book|title=WHO Model Prescribing Information: Drugs Used in Parasitic Diseases|date=1995|publisher=WHO|isbn=92 4 140104 4|edition=2nd|url=http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.2.html|chapter=Protozoa: Amoebiasis and giardiasis: Diloxanide|deadurl=no|archiveurl=https://web.archive.org/web/20160912214427/http://apps.who.int/medicinedocs/en/d/Jh2922e/2.1.2.html|archivedate=2016-09-12|df=}}</ref> It is considered second line treatment for [[Amoebiasis|infection with amoebas]] when no symptoms are present but the person is passing cysts, in places where infections are not common.<ref name=Nat2006rev/><ref name="pmid1520794">{{cite journal |vauthors=McAuley JB, Herwaldt BL, Stokes SL |title=Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States |journal=Clin. Infect. Dis. |volume=15 |issue=3 |pages=464–8 |year=1992 |pmid=1520794 |doi=10.1093/clind/15.3.464|display-authors=etal}}</ref> [[Paromomycin]] is considered the first line treatment for these cases.

For people who are symptomatic, it is used after treatment with ambecides that can penetrate tissue, like [[metronidazole]] or [[tinidazole]]. Diloxanide is considered second-line, while paromomycin is considered first line for this use as well.<ref name=Nat2006rev/><ref>{{Cite book|title=Pharmacotherapeutics For Advanced Practice: A Practical Approach|last=Arcangelo|first=Virginia Poole|publisher=Lippincott Williams and Wilkins|year=2006|isbn=978-0-7817-5784-3|location=|pages=441|quote=|via=}}</ref>

==Adverse effects==
Side effects include flatulence, itchiness, and hives. In general, the use of diloxanide is well tolerated with minimal toxicity. Although there is no clear risk of harm when used during pregnancy, diloxanide should be avoided in the first trimester if possible.<ref name=WHOmodel1995/>

Diloxanide furoate is not recommended in women who are breast feeding, and in children <2 years of age.<ref name=Kucers2012/>

== Pharmacology ==
Diloxanide furoate destroys [[trophozoites]] of ''E. Histolica'' and prevents ameobic cyst formation.<ref name=Gupta2004rev>{{cite journal|last1=Gupta|first1=Y. K.|last2=Gupta|first2=Madhur|last3=Aneja|first3=S.|last4=Kohli|first4=K.|title=Current drug therapy of protozoal diarrhoea|journal=The Indian Journal of Pediatrics|date=January 2004|volume=71|issue=1|pages=55–58|doi=10.1007/BF02725657|pmid=14979387}}</ref> The exact mechanism of diloxanide is unknown.<ref name=UKlabel2015/> Diloxanide is structurally related to chloramphenicol and may act in a similar fashion by blocking protein synthesis.<ref name=Kucers2012/>

The [[prodrug]], diloxanide furoate, is metabolized in the gastrointestinal tract to release the active drug, diloxanide.<ref name=UKlabel2015>{{cite web|title=Diloxanide 500 mg Tablets - Summary of Product Characteristics|url=https://www.medicines.org.uk/emc/medicine/10787|publisher=UK Electronic Medicines Compendium|accessdate=11 November 2016|date=March 31, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161111191427/https://www.medicines.org.uk/emc/medicine/10787|archivedate=11 November 2016|df=}}</ref>

90% of each dose is excreted in the urine and the other 10% is excreted in the feces.<ref name=UKlabel2015/>

==Society and culture==
Diloxanide furoate is on the [[World Health Organization's List of Essential Medicines]], of the most important medication needed in a basic [[health system]].<ref name=WHOlist>{{cite web|title=WHO Model List of Essential Medicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013|deadurl=no|archiveurl=https://web.archive.org/web/20140423005004/http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|archivedate=23 April 2014|df=}}</ref>

The drug was discovered by [[Boots UK]] in 1956 and introduced as ''Furamide''; it was not available in much of the developed world as of 2012.<ref name=Kucers2012/> As of 2014, in the case of emergencies, diloxanide could be acquired from the Parasitic Disease Drug Service of the Centers for Disease Control and Prevention in the US.<ref>{{cite book|editor1-last=Thomas|editor1-first=Stephen J.|title=Walter Reed Army Institute of Research Tropical Medicine Course Laboratory Manual|date=2014|publisher=U.S. Department of the Army|page=34|edition=7th|url=http://wrair-www.army.mil/Documents/TropMed/LabManuals/final%20version%2015_for%20August%202014%20course.pdf|deadurl=no|archiveurl=https://web.archive.org/web/20161111200204/http://wrair-www.army.mil/Documents/TropMed/LabManuals/final%20version%2015_for%20August%202014%20course.pdf|archivedate=2016-11-11|df=}}</ref>

==References ==
{{Reflist|32em}}

{{Agents against amoebozoa}}

[[Category:Antiprotozoal agents]]
[[Category:World Health Organization essential medicines]]
[[Category:Furans]]
[[Category:Organochlorides]]
[[Category:Anilides]]
[[Category:RTT]]